However, despite several computed tomography (CT) scan studies, no signs of brain atrophy have been conclusively demonstrated in therapeutic dose users, and even the results in high dose abusers are inconclusive
et al., 2020), E ACT or F ACT (Namkung et al., 2011) which would increase the activity of TMEM16A, subsequently increasing chloride and bicarbonate transport to propel water into mucus, or decrease the activity of ENaC, reducing sodium transport intracellularly and increasing water retained in mucus, could be very beneficial but are still far from public use (Livraghi-Butrico et al., 2013
This is due to the possibility that more glycine and serine may be needed to properly catabolize the extra methionine, unintentionally leading to a shortage in these amino acids
In a 2024 review of three peptides, the FDA noted side effects like increased heart rate, chest tightening, headache, nausea, diarrhea, and elevated liver enzymes, as well as skin irritation and pain at the injection site
Clinical Presentations: Available in tablets (dragees) for maintenance or injectable solutions for acute cases (according to medical evaluation)
